MedTrace Logo

A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System

NCT02890303 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-04-27

Study results available
· View outcomes & findings →

Summary

This study will evaluate outcome in subjects who have elected to have Zepto capsulotomies during cataract surgery with phacoemulsification.

Conditions

  • Cataract

Interventions

DEVICE

Zepto System

Anterior Capsulotomy using the Zepto System.

Sponsors & Collaborators

  • Mynosys Cellular Devices, Inc.

    lead INDUSTRY

Principal Investigators

  • William Christie, M.D. · Scott & Christie and Associates P C

  • Daniel H Chang, M.D. · Empire Eye and Laser Center

  • David F Chang, M.D. · Peninsula Eye Surgery Center

  • Eric D Donnenfeld, M.D. · Lasik Garden City

  • Philip C Hoopes, M.D. · Hoopes Vision

  • John Vukich, M.D. · Davis Duehr Dean Clinic

  • Farrell C Tyson II, M.D. · Cape Coral Eye Ctr Pa

  • Vance Thompson, M.D · Vance Thompson Vision

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-12
Primary Completion
2016-12-15
Completion
2017-03-14
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02890303 on ClinicalTrials.gov